U.S. markets close in 3 hours 7 minutes
  • S&P 500

    3,296.27
    -19.30 (-0.58%)
     
  • Dow 30

    27,220.59
    -67.59 (-0.25%)
     
  • Nasdaq

    10,850.25
    -113.38 (-1.03%)
     
  • Russell 2000

    1,486.89
    -10.07 (-0.67%)
     
  • Crude Oil

    40.23
    +0.43 (+1.08%)
     
  • Gold

    1,870.30
    -37.30 (-1.96%)
     
  • Silver

    23.23
    -1.30 (-5.29%)
     
  • EUR/USD

    1.1693
    -0.0016 (-0.14%)
     
  • 10-Yr Bond

    0.6840
    +0.0200 (+3.01%)
     
  • GBP/USD

    1.2763
    +0.0027 (+0.21%)
     
  • USD/JPY

    105.3710
    +0.4470 (+0.43%)
     
  • BTC-USD

    10,510.39
    -31.36 (-0.30%)
     
  • CMC Crypto 200

    222.66
    +8.69 (+4.06%)
     
  • FTSE 100

    5,899.26
    +69.80 (+1.20%)
     
  • Nikkei 225

    23,346.49
    -13.81 (-0.06%)
     

Vaccine Economics: Where Profit and Public Health Collide

As government and private money pour into the global race for a Covid-19 vaccine, drugmakers are under great pressure to keep the shot affordable while also keeping investors happy. WSJ explains what this means for the final price tag of the jabs. Illustration: Crystal Tai